Jalal Zahraa, Paudyal Vibhu, Al-Arkee Shahad, Dyson Gillian, Marriott John
School of Pharmacy, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TT, UK.
Patient and Public Involvement in Research Representative UK, Birmingham B15 2TT, UK.
Pharmacy (Basel). 2020 Jan 24;8(1):13. doi: 10.3390/pharmacy8010013.
to conduct a Patient and Public Involvement (PPI) focus group session. To help inform the design of a clinical pharmacy intervention in primary care for patients after a coronary event.
this study followed a public involvement method. Community members of the public and community engaged research patients who had experienced myocardial infarction where invited to actively take part in a focus group discussion. This is to share past experiences and provide input and advice into the design of a potential research proposal. The session took place at a cardiac rehabilitation centre.
four key themes were identified from the focus group these included: experiences with pharmacy and primary care services, medicines knowledge, the pharmacist role and building rapport with healthcare professionals. Nine participants and three researchers attended the PPI discussion session. Seven of the participants were patients who had experienced a cardiac event in the last three months and two were carers. Primary care pharmacy services both clinical and public health were not very familiar to the participants. Different experiences with clinical pharmacy services were reported by participants, while one experience was reported to be helpful others perceived community pharmacists to be to be busy and isolated behind a counter. A general practice GP based specialist nurse was a familiar model of care unlike a specialist clinical pharmacist GP based care role. Participants reported limited time in GP consultations and the need to book double appointments. Participants stressed the need to receive consistent information about their disease and medication from different professionals involved in their care. Different views were expressed regarding the ability to build rapport with a clinical pharmacist when compared to a GP. Input on study outcomes and design was provided by participants.
participants in this session mentioned that a clinical pharmacy intervention after hospital discharge would be useful for their continuity of care. Plans are in place to continue to involve patients and the public in the write up, ethics and dissemination of the potential clinical pharmacy proposal.
开展一次患者及公众参与（PPI）焦点小组会议，以协助为冠心病事件后初级保健中的临床药学干预设计提供信息。
本研究采用公众参与方法。邀请公众社区成员以及经历过心肌梗死的社区参与研究患者积极参加焦点小组讨论，分享过往经历，并为潜在研究方案的设计提供意见和建议。会议在心脏康复中心举行。
从焦点小组中确定了四个关键主题，包括：药房和初级保健服务体验、药物知识、药剂师角色以及与医疗保健专业人员建立融洽关系。九名参与者和三名研究人员参加了PPI讨论会。其中七名参与者是在过去三个月内经历过心脏事件的患者，两名是护理人员。参与者对初级保健药房服务（包括临床和公共卫生服务）不太熟悉。参与者报告了不同的临床药学服务体验，虽然有一次体验被认为有帮助，但其他人认为社区药剂师很忙，躲在柜台后面很孤立。与基于全科医生（GP）的专科临床药剂师护理角色不同，基于全科医生的专科护士是一种熟悉的护理模式。参与者报告在全科医生咨询中的时间有限，需要预约两次就诊。参与者强调需要从参与其护理的不同专业人员那里获得关于其疾病和药物的一致信息。与全科医生相比，对于与临床药剂师建立融洽关系的能力，表达了不同的观点。参与者提供了关于研究结果和设计的意见。
本次会议的参与者提到出院后的临床药学干预对他们的护理连续性会有帮助。已制定计划，继续让患者和公众参与潜在临床药学方案的撰写、伦理审查和传播。
